Author:
Sutherland Jamie N.,Chang Christine,Yoder Sandra M.,Rock Michael T.,Maynard Jennifer A.
Abstract
ABSTRACTDespite more than 50 years of vaccination, disease caused by the bacteriumBordetella pertussispersists, with rates increasing in industrialized countries over the past decade. This rise may be attributed to several factors, including increased surveillance, emergence of vaccine escape variants, waning immunity in adults, and the introduction of acellular subunit vaccines, which include chemically detoxified pertussis toxin (PTd). Two potently protective epitopes on pertussis toxin (PTx) are recognized by the monoclonal antibodies 1B7 and 11E6, which inhibit catalytic and cell-binding activities, respectively. In order to determine whether the PTx exposure route affects antibody responses to these epitopes, we analyzed sera from 30 adults with confirmed pertussis exposure and from 30 recently vaccinated adults for specific anti-PTx antibody responses andin vitroCHO cell neutralization titers. While overall titers against PTx and the genetically detoxified variant, PTg, containing the R9K and E129G substitutions, were similar in the two groups, titers against specific epitopes depended on the exposure route. Natural infection resulted in significantly higher titers of anti-PTx-subunit 1, 1B7-like, and 11E6-like antibodies, while acellular vaccination resulted in significantly higher titers of antibodies recognizing PTd. We also observed a correlation betweenin vitroprotection and the presence of 1B7-like and 11E6-like antibodies. Notably, chemical detoxification, as opposed to genetic inactivation, alters the PTx tertiary and quaternary structure, thereby affecting conformational epitopes and recognition of PTx by 1B7 and 11E6. The lower levels of serum antibodies recognizing clinically relevant epitopes after vaccination with PTd support inclusion of PTg in future vaccines.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference44 articles.
1. Outbreaks of respiratory illness mistakenly attributed to pertussis—-New Hampshire, Massachusetts, and Tennessee, 2004-2006;Anonymous;MMWR Morb. Mortal. Wkly. Rep.,2007
2. Mapping of a protective epitope of pertussis toxin by in vitro refolding of recombinant fragments;Bartoloni;Nat. Biotechnol.,1988
3. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP);Broder;MMWR Recomm. Rep.,2006
4. Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin. Pediatr;Bruss;Infect. Dis. J.,1999
5. Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model;Bruss;Clin. Diagn. Lab. Immunol.,1999
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献